Search research articles
Contact Us
Filters
Showing results (11-20 of 81) with videos related to
Page
of 9
Sort By:
Hematology (Amsterdam, Netherlands)
|
May 24, 2021
Impact of obesity on survival of patients with myelodysplastic syndromes
Zaker Schwabkey, Najla Al Ali, David Sallman, et al.
Leukemia
|
June 23, 2020
Characterization of myelodysplastic syndromes (MDS) with T-cell large granular lymphocyte proliferations (LGL)
Rami S Komrokji, Najla Al Ali, David Sallman, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 14, 2016
Eltrombopag Use in Patients With Chronic Myelomonocytic Leukemia (CMML): A Cautionary Tale
Hanadi Ramadan, Vu H Duong, Najla Al Ali, et al.
Leukemia & Lymphoma
|
April 21, 2020
A sequential two-stage dose escalation study of eltrombopag in patients with myelodysplastic syndrome and thrombocytopenia after hypomethylating agent failure
Vu H Duong, Najla Al Ali, Ling Zhang, et al.
Cancer
|
September 30, 2011
Validation of the MD Anderson Prognostic Risk Model for patients with myelodysplastic syndrome
Rami S Komrokji, Maria Corrales-Yepez, Najla Al Ali, et al.
Blood Cancer Journal
|
November 4, 2022
Assessing the role of venetoclax in combination with hypomethylating agents in higher risk myelodysplastic syndrome
Rami S Komrokji, Avani M Singh, Najla Al Ali, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 4, 2022
Comparison of Different Treatment Strategies for Blast-Phase Myeloproliferative Neoplasms
Franco Castillo Tokumori, Najla Al Ali, Onyee Chan, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 12, 2020
Retrospective Analysis of the Clinical Use and Benefit of Lenalidomide and Thalidomide in Myelofibrosis
Franco Castillo-Tokumori, Chetasi Talati, Najla Al Ali, et al.
British Journal of Haematology
|
June 24, 2022
Splicing factor 3B subunit 1 (SF3B1) mutation in the context of therapy-related myelodysplastic syndromes
Virginia O Volpe, Najla Al Ali, Onyee Chan, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 26, 2018
Clinical Outcomes With Ring Sideroblasts and SF3B1 Mutations in Myelodysplastic Syndromes: MDS Clinical Research Consortium Analysis
Yazan Migdady, John Barnard, Najla Al Ali, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 81) with videos related to
Sort By:
Page
of 9
Hematology (Amsterdam, Netherlands)
|
May 24, 2021
Impact of obesity on survival of patients with myelodysplastic syndromes
Zaker Schwabkey, Najla Al Ali, David Sallman, et al.
Leukemia
|
June 23, 2020
Characterization of myelodysplastic syndromes (MDS) with T-cell large granular lymphocyte proliferations (LGL)
Rami S Komrokji, Najla Al Ali, David Sallman, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 14, 2016
Eltrombopag Use in Patients With Chronic Myelomonocytic Leukemia (CMML): A Cautionary Tale
Hanadi Ramadan, Vu H Duong, Najla Al Ali, et al.
Leukemia & Lymphoma
|
April 21, 2020
A sequential two-stage dose escalation study of eltrombopag in patients with myelodysplastic syndrome and thrombocytopenia after hypomethylating agent failure
Vu H Duong, Najla Al Ali, Ling Zhang, et al.
Cancer
|
September 30, 2011
Validation of the MD Anderson Prognostic Risk Model for patients with myelodysplastic syndrome
Rami S Komrokji, Maria Corrales-Yepez, Najla Al Ali, et al.
Blood Cancer Journal
|
November 4, 2022
Assessing the role of venetoclax in combination with hypomethylating agents in higher risk myelodysplastic syndrome
Rami S Komrokji, Avani M Singh, Najla Al Ali, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 4, 2022
Comparison of Different Treatment Strategies for Blast-Phase Myeloproliferative Neoplasms
Franco Castillo Tokumori, Najla Al Ali, Onyee Chan, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 12, 2020
Retrospective Analysis of the Clinical Use and Benefit of Lenalidomide and Thalidomide in Myelofibrosis
Franco Castillo-Tokumori, Chetasi Talati, Najla Al Ali, et al.
British Journal of Haematology
|
June 24, 2022
Splicing factor 3B subunit 1 (SF3B1) mutation in the context of therapy-related myelodysplastic syndromes
Virginia O Volpe, Najla Al Ali, Onyee Chan, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 26, 2018
Clinical Outcomes With Ring Sideroblasts and SF3B1 Mutations in Myelodysplastic Syndromes: MDS Clinical Research Consortium Analysis
Yazan Migdady, John Barnard, Najla Al Ali, et al.
Page
of 9